 | Cancer Genetics, Inc. Estimate Momentum
www.nasdaq.com - March 18 at 8:05 PM |
 | -$0.13 EPS Expected for Cancer Genetics Inc (CGIX) This Quarter
www.americanbankingnews.com - March 7 at 1:18 AM |
 | Could The Cancer Genetics, Inc. (NASDAQ:CGIX) Ownership Structure Tell Us Something Useful?
finance.yahoo.com - February 14 at 6:28 PM |
 | Cancer Genetics, Inc. Announces Closing of Public Offering of Common Stock - GlobeNewswire
globenewswire.com - February 1 at 8:19 AM |
 | Cancer Genetics Inc.
www.barrons.com - January 31 at 8:11 AM |
 | Mid-Afternoon Market Update: Sanmina Jumps On Upbeat Earnings; Cancer Genetics Shares Slide
www.benzinga.com - January 29 at 6:18 PM |
 | Cancer Genetics announces pricing of common stock, Shares down 15.7%
seekingalpha.com - January 29 at 8:10 AM |
| Cancer Genetics down 16% premarket on stock offering
seekingalpha.com - January 29 at 8:10 AM |
| Cancer Genetics, Inc. Announces Pricing of $3.5 Million Public Offering of Common Stock
finance.yahoo.com - January 29 at 8:10 AM |
| Cancer Genetics, Inc. Announces Proposed Public Offering of Common Stock - GlobeNewswire
globenewswire.com - January 28 at 6:25 PM |
| Insider Buys Of The Week: Cancer Genetics, Dish Network, Valvoline - Benzinga
www.benzinga.com - January 21 at 6:03 PM |
| Cancer Genetics +16% on loan forbearance deal
seekingalpha.com - January 17 at 8:14 AM |
| Cancer Genetics, Inc. Announces Closing of Public Offering of Common Stock
finance.yahoo.com - January 14 at 6:11 PM |
| Cancer Genetics down 28% on pricing equity offering
seekingalpha.com - January 10 at 8:17 AM |
| Cancer Genetics, Inc. Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - January 10 at 8:16 AM |
| Cancer Genetics readies stock offering; shares down 6% after hours
seekingalpha.com - January 9 at 7:05 PM |
| Cancer Genetics, Inc. Announces Proposed Public Offering of Common Stock
finance.yahoo.com - January 9 at 7:05 PM |
| Cancer Genetics Strengthens Management Team with Appointment of William Finger as Executive Vice President, Precision Medicine and Pharma Services
finance.yahoo.com - January 9 at 8:23 AM |
 | Cancer Genetics (CGIX) Terminates Proposed Merger with NovellusDx
www.streetinsider.com - December 17 at 5:47 PM |
| Cancer Genetics Terminates Proposed Merger with NovellusDx
finance.yahoo.com - December 17 at 8:12 AM |
| Today's Research Reports on Trending Tickers: Adial Pharmaceuticals and Cancer Genetics
finance.yahoo.com - December 14 at 8:15 AM |
| Cancer Genetics (CGIX) Reports Q3 Loss, Lags Revenue Estimates
finance.yahoo.com - November 20 at 8:14 AM |
| Cancer Genetics Reports Third Quarter 2018 Financial Results and Provides Strategic Business Updates
finance.yahoo.com - November 19 at 5:25 PM |
| Cancer Genetics: 3Q Earnings Snapshot
finance.yahoo.com - November 19 at 5:25 PM |
| Form 425 CANCER GENETICS, INC Filed by: CANCER GENETICS, INC
www.streetinsider.com - November 16 at 6:01 PM |
| Cancer Genetics (CGIX) Appoints Glenn Miles as Chief Financial Officer
www.streetinsider.com - November 15 at 8:15 AM |
| Cancer Genetics Appoints Glenn Miles as Chief Financial Officer
finance.yahoo.com - November 14 at 5:24 PM |
| Myriad Presents Two New Studies at the Western Section of the American Urological Association
www.nasdaq.com - November 2 at 8:10 AM |
| Will Cancer Genetics (CGIX) Report Negative Earnings Next Week? What You Should Know
finance.yahoo.com - November 1 at 6:10 PM |
| Cancer Genetics Issues Letter to Shareholders
finance.yahoo.com - October 16 at 8:18 AM |
| Cancer Genetics up 16% on collaborating with Cellaria for precision medicine tools
seekingalpha.com - October 8 at 4:51 PM |
| Global Genetic Testing Market to Witness a CAGR of 12.2% during 2018-2024
globenewswire.com - October 8 at 8:11 AM |
| Cancer Genetics and Cellaria Partner on Precision Medicine Tools
finance.yahoo.com - October 8 at 8:11 AM |
| Robbins Arroyo LLP: Cancer Genetics, Inc. (CGIX) Sued by Shareholders in Recently Filed Class Action
finance.yahoo.com - September 29 at 8:09 AM |
| Cancer Genetics Offers Oncomine Comprehensive Assay to Drive Clinical Trials
finance.yahoo.com - September 20 at 4:57 PM |
| Cancer Genetics and NovellusDx Sign Definitive Agreement to Merge
finance.yahoo.com - September 18 at 5:01 PM |
| Chardan Advises NovellusDX in Cross-Border Biotech Merger
finance.yahoo.com - September 18 at 5:01 PM |
| Four years after buying Morrisville firm, this out-of-town CEO wants to bolster NC ops
finance.yahoo.com - August 17 at 5:40 PM |
| Cancer Genetics Q2 revenues up 6%; shares up 4% premarket
seekingalpha.com - August 15 at 8:15 AM |
| Edited Transcript of CGIX earnings conference call or presentation 14-Aug-18 12:30pm GMT
finance.yahoo.com - August 15 at 8:15 AM |
| Cancer Genetics, Inc. (CGIX) CEO John Roberts on Q2 2018 Results - Earnings Call Transcript
seekingalpha.com - August 14 at 5:41 PM |
| Cancer Genetics beats by $0.03, misses on revenue
seekingalpha.com - August 14 at 8:13 AM |
| Cancer Genetics Reports Second Quarter 2018 Financial Results and Provides Strategic Business Updates
finance.yahoo.com - August 14 at 8:13 AM |
| Cancer Genetics: 2Q Earnings Snapshot
finance.yahoo.com - August 14 at 8:13 AM |
 | IBM Bet Billions That Watson Could Improve Cancer Treatment. It Hasn't Worked.
www.wsj.com - August 11 at 8:10 AM |
| Cancer Genetics to Report Second Quarter 2018 Financial Results on August 14, 2018
finance.yahoo.com - August 7 at 5:32 PM |
 | Why pharma giant GSK just made a $300 million bet on 23andMe's approach to finding new medicines
www.businessinsider.com - July 26 at 8:12 AM |
| The CEO of Roche Pharmaceuticals explains why the company became a deal-machine in 2018
www.businessinsider.com - July 26 at 8:12 AM |
| Cancer Genetics Closes $2.625 million Convertible Note Financing
finance.yahoo.com - July 18 at 4:54 PM |
| Cancer Genetics Strengthens Management Team with Appointment of Michael McCartney as Chief Commercial Officer
finance.yahoo.com - June 12 at 8:14 AM |
